Prognostic Value of Long Noncoding RNA DLEU2 and Its Relationship with Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma

References

• Federico P, Petrillo A, Giordano P, et al. Immune checkpoint inhibitors in hepatocellular carcinoma: current status and novel perspectives. Cancers. 2020;12(10):3025. doi:10.3390/cancers12103025
   PubMed Web of Science ®Google Scholar
• Xu T, Gao S, Ruan H, et al. METTL14 acts as a potential regulator of tumor immune and progression in clear cell renal cell carcinoma. Front Genet. 2021;12:609174. doi:10.3389/fgene.2021.609174
   PubMed Web of Science ®Google Scholar
• Thouvenin J, Martínez Chanzá N, Alhalabi O, et al. Efficacy of immune checkpoint inhibitors in upper tract urothelial carcinomas: current knowledge and future directions. Cancers. 2021;13(17):4341. doi:10.3390/cancers13174341
   PubMed Web of Science ®Google Scholar
• Yu EM, Linville L, Rosenthal M, Aragon-Ching JB. A contemporary review of immune checkpoint inhibitors in advanced clear cell renal cell carcinoma. Vaccines. 2021;9(8):919. doi:10.3390/vaccines9080919
   Web of Science ®Google Scholar
• Zheng X, Jin W, Wang S, Ding H. Progression on the roles and mechanisms of tumor-infiltrating T lymphocytes in patients with hepatocellular carcinoma. Front Immunol. 2021;12:729705. doi:10.3389/fimmu.2021.729705
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Koyama S. Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies. J Immunother Cancer. 2021;9(7):e002591.
   PubMed Web of Science ®Google Scholar
• Peng B, Yan Y, Xu Z. The bioinformatics and experimental analysis of AlkB family for prognosis and immune cell infiltration in hepatocellular carcinoma. PeerJ. 2021;9:e12123. doi:10.7717/peerj.12123
   PubMed Web of Science ®Google Scholar
• Wang B, Chen D, Hua H. TBC1D3 family is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma. Mol Ther Oncolytics. 2021;22:528–538. doi:10.1016/j.omto.2021.06.014
   PubMed Web of Science ®Google Scholar
• Wang S, Ma X, Ying Y, et al. Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma. Cancer Cell Int. 2021;21(1):341. doi:10.1186/s12935-021-02046-z
   PubMed Web of Science ®Google Scholar
• Jacquier A, Lambert T, Delattre J-F, et al. Tumor infiltrating and peripheral CD4ILT2 T cells are a cytotoxic subset selectively inhibited by HLA-G in clear cell renal cell carcinoma patients. Cancer Lett. 2021;519:105–116. doi:10.1016/j.canlet.2021.06.018
   PubMed Web of Science ®Google Scholar
• Xue C, Gao P, Cui X, et al. ASRGL1 correlates with immune cell infiltration in hepatocellular carcinoma and can serve as a prognostic biomarker. Front Oncol. 2021;11:680070. doi:10.3389/fonc.2021.680070
   PubMed Web of Science ®Google Scholar
• Bao S, Jiang X, Jin S, Tu P, Lu J. TGF-β1 induces immune escape by enhancing PD-1 and CTLA-4 expression on T lymphocytes in hepatocellular carcinoma. Front Oncol. 2021;11:694145. doi:10.3389/fonc.2021.694145
   PubMed Web of Science ®Google Scholar
• Han S, Qi Y, Xu Y, et al. lncRNA DLEU2 promotes gastric cancer progression through ETS2 via targeting miR-30a-5p. Cancer Cell Int. 2021;21(1):376. doi:10.1186/s12935-021-02074-9
   PubMed Web of Science ®Google Scholar
• He M, Wang Y, Cai J, et al. LncRNA DLEU2 promotes cervical cancer cell proliferation by regulating cell cycle and NOTCH pathway. Exp Cell Res. 2021;402(1):112551. doi:10.1016/j.yexcr.2021.112551
   PubMed Web of Science ®Google Scholar
• Yang J, Huang Y, Dong B, Dai Y. Long noncoding RNA DLEU2 drives the malignant behaviors of thyroid cancer through mediating the miR-205-5p/TNFAIP8 axis. Endocr Connect. 2021;10(4):471–483. doi:10.1530/EC-21-0046
   PubMed Web of Science ®Google Scholar
• Guo Y, Bai M, Lin L, et al. LncRNA DLEU2 aggravates the progression of hepatocellular carcinoma through binding to EZH2. Biomed Pharmacother. 2019;118:109272. doi:10.1016/j.biopha.2019.109272
   PubMed Web of Science ®Google Scholar
• Salerno D, Chiodo L, Alfano V, et al. Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription. Gut. 2020;69(11):2016–2024. doi:10.1136/gutjnl-2019-319637
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhang J, Zhang Z, et al. The putative tumor suppressor microRNA-30a-5p modulates clear cell renal cell carcinoma aggressiveness through repression of ZEB2. Cell Death Dis. 2017;8(6):e2859. doi:10.1038/cddis.2017.252
   PubMed Web of Science ®Google Scholar
• Li G, Zhang Z, Chen Z, Liu B, Wu H. LncRNA DLEU2 is activated by STAT1 and induces gastric cancer development via targeting miR-23b-3p/NOTCH2 axis and Notch signaling pathway. Life Sci. 2021;277:119419. doi:10.1016/j.lfs.2021.119419
   PubMed Web of Science ®Google Scholar
• Li X, Xu F, Meng Q, et al. Long noncoding RNA DLEU2 predicts a poor prognosis and enhances malignant properties in laryngeal squamous cell carcinoma through the miR-30c-5p/PIK3CD/Akt axis. Cell Death Dis. 2020;11(6):472. doi:10.1038/s41419-020-2581-2
   PubMed Web of Science ®Google Scholar
• Mian M, Scandurra M, Chigrinova E, et al. Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion. Ann Oncol. 2012;23(3):729–735. doi:10.1093/annonc/mdr289
   PubMed Web of Science ®Google Scholar
• Rhodes DR, Yu J, Shanker K, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004;6(1):1–6. doi:10.1016/S1476-5586(04)80047-2
   PubMed Web of Science ®Google Scholar
• Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509–W514. doi:10.1093/nar/gkaa407
   PubMed Web of Science ®Google Scholar
• Hou GX, Liu P, Yang J, Wen S. Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan-Meier plotter. PLoS One. 2017;12(3):e0174515. doi:10.1371/journal.pone.0174515
   PubMed Web of Science ®Google Scholar
• Wang S, Xiong Y, Zhao L, et al. UCSCXenaShiny: an R/CRAN package for interactive analysis of UCSC xena data. Bioinformatics. 2021. doi:10.1093/bioinformatics/btab561
   Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–658. doi:10.1016/j.neo.2017.05.002
   PubMed Web of Science ®Google Scholar
• Azimi F, Scolyer RA, Rumcheva P, et al. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J Clin Oncol. 2012;30(21):2678–2683. doi:10.1200/JCO.2011.37.8539
   PubMed Web of Science ®Google Scholar
• Zhou F, Shen D, Xiong Y, et al. CTHRC1 is a prognostic biomarker and correlated with immune infiltrates in kidney renal papillary cell carcinoma and kidney renal clear cell carcinoma. Front Oncol. 2020;10:570819. doi:10.3389/fonc.2020.570819
   PubMed Web of Science ®Google Scholar
• Li N, Zeng Y, Tai M, et al. Analysis of the prognostic value and gene expression mechanism of in lung adenocarcinoma. Front Mol Biosci. 2021;8:688274. doi:10.3389/fmolb.2021.688274
   PubMed Web of Science ®Google Scholar
• Koelsche C, Benhamida JK, Kommoss FKF, et al. Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature. Mod Pathol. 2021. doi:10.1038/s41379-021-00874-y
   Web of Science ®Google Scholar
• Liu Y, Corcoran M, Rasool O, et al. Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia. Oncogene. 1997;15(20):2463–2473. doi:10.1038/sj.onc.1201643
   PubMed Web of Science ®Google Scholar
• Xu W, Wang B, Cai Y, Guo C, Liu K, Yuan C. DLEU2: a meaningful long noncoding RNA in oncogenesis. Curr Pharm Des. 2021;27(20):2337–2343. doi:10.2174/1381612826666201026150857
   PubMed Web of Science ®Google Scholar
• Dong P, Xiong Y, Konno Y, et al. Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway. J Exp Clin Cancer Res. 2021;40(1):216. doi:10.1186/s13046-021-02018-1
   PubMed Web of Science ®Google Scholar
• Klein U, Lia M, Crespo M, et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell. 2010;17(1):28–40. doi:10.1016/j.ccr.2009.11.019
   PubMed Web of Science ®Google Scholar
• Poli A, Abdul-Hamid S, Zaurito AE, et al. PIP4Ks impact on PI3K, FOXP3, and UHRF1 signaling and modulate human regulatory T cell proliferation and immunosuppressive activity. Proc Natl Acad Sci U S A. 2021;118(31):e2010053118. doi:10.1073/pnas.2010053118
   PubMed Web of Science ®Google Scholar
• Yang C, Wu S, Mou Z, et al. Transcriptomic analysis identified ARHGAP family as a novel biomarker associated with tumor-promoting immune infiltration and nanomechanical characteristics in bladder cancer. Front Cell Dev Biol. 2021;9:657219. doi:10.3389/fcell.2021.657219
   PubMed Web of Science ®Google Scholar
• Sawant A, Hensel JA, Chanda D, et al. Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells. J Immunol. 2012;189(9):4258–4265. doi:10.4049/jimmunol.1101855
   PubMed Web of Science ®Google Scholar
• Xing Z, Zhang M, Liu J, Liu G, Feng K, Wang X. LINC00337 induces tumor development and chemoresistance to paclitaxel of breast cancer by recruiting M2 tumor-associated macrophages. Mol Immunol. 2021;138:1–9. doi:10.1016/j.molimm.2021.07.009
   PubMed Web of Science ®Google Scholar
• Xu W, Liu WR, Xu Y, et al. Hexokinase 3 dysfunction promotes tumorigenesis and immune escape by upregulating monocyte/macrophage infiltration into the clear cell renal cell carcinoma microenvironment. Int J Biol Sci. 2021;17(9):2205–2222.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Cai MY, Weng DS, et al. PD-L1 expression patterns in tumour cells and their association with CD8 tumour infiltrating lymphocytes in clear cell renal cell carcinoma. J Cancer. 2019;10(5):1154–1161. doi:10.7150/jca.29052
   PubMed Web of Science ®Google Scholar
• Qi Y, Xia Y, Lin Z, et al. Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients. Cancer Immunol Immunother. 2020;69(8):1565–1576. doi:10.1007/s00262-020-02563-2
   PubMed Web of Science ®Google Scholar
• Cui K, Wu X, Gong L, et al. Comprehensive characterization of integrin subunit genes in human cancers. Front Oncol. 2021;11:704067. doi:10.3389/fonc.2021.704067
   PubMed Web of Science ®Google Scholar
• Morenos L, Chatterton Z, Ng JL, et al. Hypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a/16-1. Mol Cancer. 2014;13:123. doi:10.1186/1476-4598-13-123
   PubMed Web of Science ®Google Scholar
• Graf RP, Eskander R, Brueggeman L, Stupack DG. Association of copy number variation signature and survival in patients with serous ovarian cancer. JAMA Netw Open. 2021;4(6):e2114162. doi:10.1001/jamanetworkopen.2021.14162
   PubMed Web of Science ®Google Scholar
• Pariyar M, Johns A, Thorne RF, Scott RJ, Avery-Kiejda KA. Copy number variation in triple negative breast cancer samples associated with lymph node metastasis. Neoplasia. 2021;23(8):743–753. doi:10.1016/j.neo.2021.05.016
   PubMed Web of Science ®Google Scholar